Status:
COMPLETED
Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Pneumococcal Pneumonia
Eligibility:
All Genders
19-64 years
Phase:
NA
Brief Summary
The goals of the study are to determine the pneumococcal polysaccharide vaccination rate in patients with diabetes before and after community pharmacist education and intervention. Assess barriers of ...
Detailed Description
Three geographically and socioeconomically diverse Kroger pharmacies will be selected in the greater Richmond area. Eligible patients include patients with diabetes between the ages of 19 and 64 and p...
Eligibility Criteria
Inclusion
- Patients with diabetes
- Patients who have filled a prescription for at least one diabetes medication in the past 90 days
Exclusion
- Patients with a known history pneumococcal polysaccharide vaccination
- Patients with an allergy to any component of the pneumococcal polysaccharide vaccine
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2019
Estimated Enrollment :
431 Patients enrolled
Trial Details
Trial ID
NCT03851978
Start Date
November 1 2018
End Date
February 28 2019
Last Update
March 15 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Kroger Pharmacy
Midlothian, Virginia, United States, 23113
2
Kroger Pharmacy
Richmond, Virginia, United States, 23230
3
Kroger Pharmacy
Richmond, Virginia, United States, 23233
4
Virginia Commonwealth University
Richmond, Virginia, United States, 23298